In addition to the well-recognized transport function of lipoproteins, a large body of evidence has demonstrated that lipoproteins also play an important role in host defense as part of the innate immune system (for review see (1) Furthermore, the changes in lipid metabolism often occur indirectly through decreases in certain pathways shunting substrate into other pathways. For example, the increase in serum triglyceride levels that characterizes the APR is in part mediated by a decrease in fatty acid storage and oxidation in adipose tissue and muscle, which coupled with increased lipolysis, increases the flux of fatty acids to the liver. Hepatic fatty acid oxidation is also decreased, directing the fatty acids into triglyceride synthesis, resulting in increased VLDL formation and secretion (1) . These changes are mediated by decreases in nuclear hormone receptors including RXR, PPAR-α, and PPAR-γ, as well as decreases in co-activators such as PGC- 1α & β(1, 7) .
Similar to apolipoprotein A-I, apolipoprotein E also plays an important role in host defense, neutralizing LPS, protecting from Klebsiella pneumoniae and Listeria monocytogenes infection, inhibiting malaria sporozoite invasion, and modulating T-cell activation (1, (8) (9) (10) . Studies have shown that apolipoprotein E deficient mice demonstrate increased toxicity to LPS administration or experimental Klebsiella or Candida albicans infections. Despite the importance of apolipoprotein E, the regulation of apolipoprotein E during the APR was confusing. Apolipoprotein E mRNA levels decrease in liver and in peripheral cells such as macrophages like a classic negative APR protein, but apolipoprotein E levels in the circulation are maintained or even increased in sepsis and HIV infection, consistent with apolipoprotein E being a positive APR protein (1, 11) . In this issue of the Journal of Lipid Research Li et al now clarify the mechanisms underlying the regulation of apolipoprotein E during infection (12) . In mice, apolipoprotein E is mostly associated with HDL, yet Li et al demonstrate that its clearance is mediated principally by hepatic LDL receptors. They show that during the APR, LDL receptor levels decrease in the liver, leading to a decrease in apolipoprotein E clearance resulting in increased circulating apolipoprotein E. Thus, despite the decrease in apolipoprotein E mRNA levels in multiple tissues during the APR, serum apolipoprotein E levels actually increase and thereby could play an important role in host defense.
In contrast to the infection-induced decrease in hepatic LDL receptor levels, Li et al further show that LDL receptors increase on macrophages (12) , which would facilitate the delivery of lipids to the cells at the front line of host defense. This up-regulation of LDL receptors joins a growing list of changes that occur in the macrophage, which would promote lipid storage and foam cell formation (1, 13) . Such changes maybe beneficial from the perspective of host defense, as the macrophage utilizes neutral lipids to kill invading microorganisms (14) . However, if such changes are chronic it is likely that these changes will increase the risk of atherosclerosis. From our modern perspective, we are most concerned with atherosclerosis, but we should admire the multiple mechanisms by which lipoproteins and apolipoproteins are active in fighting infection and inflammation.
And perhaps we can learn to harness these evolutionarily old pathways in the future to treat infectious diseases without worsening or even decreasing atherosclerosis.
